The potential role of nemonoxacin for treatment of common infections
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The potential role of nemonoxacin for treatment of common infections
Authors
Keywords
-
Journal
EXPERT OPINION ON PHARMACOTHERAPY
Volume 16, Issue 2, Pages 263-270
Publisher
Informa Healthcare
Online
2014-12-22
DOI
10.1517/14656566.2015.978288
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Efficacy and Safety of Gentamicin Plus Azithromycin and Gemifloxacin Plus Azithromycin as Treatment of Uncomplicated Gonorrhea
- (2014) Robert D. Kirkcaldy et al. CLINICAL INFECTIOUS DISEASES
- Novel antibiotic treatment for skin and soft tissue infection
- (2014) Matthew S. Dryden CURRENT OPINION IN INFECTIOUS DISEASES
- Nemonoxacin: First Global Approval
- (2014) Raewyn M. Poole DRUGS
- Nemonoxacin (TG-873870) for treatment of community-acquired pneumonia
- (2014) Chung-Chih Lai et al. Expert Review of Anti-Infective Therapy
- Antibiotic Prescribing Practices in a Multicenter Cohort of Patients Hospitalized for Acute Bacterial Skin and Skin Structure Infection
- (2014) Timothy C. Jenkins et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalised with pneumonia in US and European hospitals: Results from the SENTRY Antimicrobial Surveillance Program, 2009–2012
- (2014) Helio S. Sader et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Fluoroquinolone resistance: mechanisms, impact on bacteria, and role in evolutionary success
- (2014) Liam S. Redgrave et al. TRENDS IN MICROBIOLOGY
- In VitroActivity of Nemonoxacin, a Novel Nonfluorinated Quinolone Antibiotic, against Chlamydia trachomatis and Chlamydia pneumoniae
- (2013) Kobkul Chotikanatis et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Overview of Severe Clostridium difficile Infection
- (2013) Stephen R. Eaton et al. CRITICAL CARE CLINICS
- The changing epidemiology of Clostridium difficile infection
- (2013) Hitoshi Honda et al. CURRENT OPINION IN GASTROENTEROLOGY
- Fidaxomicin: A Review of Its Use in Patients with Clostridium difficile Infection
- (2013) Lesley J. Scott DRUGS
- Acute Bacterial Skin Infections: Developments Since the 2005 Infectious Diseases Society of America (IDSA) Guidelines
- (2013) Gregory J. Moran et al. JOURNAL OF EMERGENCY MEDICINE
- The true cost of antimicrobial resistance
- (2013) R. Smith et al. BMJ-British Medical Journal
- Characterizations of Clinical Isolates of Clostridium difficile by Toxin Genotypes and by Susceptibility to 12 Antimicrobial Agents, Including Fidaxomicin (OPT-80) and Rifaximin: a Multicenter Study in Taiwan
- (2012) Chun-Hsing Liao et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Safety and Clinical Pharmacokinetics of Nemonoxacin, a Novel Non-Fluorinated Quinolone, in Healthy Chinese Volunteers Following Single and Multiple Oral Doses
- (2012) Beining Guo et al. CLINICAL DRUG INVESTIGATION
- 2012 Infectious Diseases Society of America Clinical Practice Guideline for the Diagnosis and Treatment of Diabetic Foot Infections
- (2012) B. A. Lipsky et al. CLINICAL INFECTIOUS DISEASES
- Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea
- (2012) Magnus Unemo et al. Future Microbiology
- Efficacy and safety of IV/PO moxifloxacin and IV piperacillin/tazobactam followed by PO amoxicillin/clavulanic acid in the treatment of diabetic foot infections: results of the RELIEF study
- (2012) N. C. Schaper et al. INFECTION
- Updated antibiotic resistance and clinical spectrum of infections caused by Streptococcus pneumoniae in Taiwan: Emphasis on risk factors for penicillin nonsusceptibilities
- (2012) Hsih-Yeh Tsai et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Cold-induced stress increases the intensity of Chlamydia genital infection in mice
- (2012) Tesfaye Belay et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- The Emerging Threat of Untreatable Gonococcal Infection
- (2012) Gail A. Bolan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antimicrobial Susceptibilities and Molecular Epidemiology of Clinical Isolates ofClostridium difficilein Taiwan
- (2011) Yi-Chun Lin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
- (2011) Catherine Liu et al. CLINICAL INFECTIOUS DISEASES
- Guidelines for the management of adult lower respiratory tract infections - Full version
- (2011) M. Woodhead et al. CLINICAL MICROBIOLOGY AND INFECTION
- A randomized trial of the efficacy and safety of sequential intravenous/oral moxifloxacin monotherapy versus intravenous piperacillin/tazobactam followed by oral amoxicillin/clavulanate for complicated skin and skin structure infections
- (2011) Inge C. Gyssens et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Quinolone Resistance: Much More than Predicted
- (2011) Alvaro Hernández et al. Frontiers in Microbiology
- Efficacy and Safety of Nemonoxacin versus Levofloxacin for Community-Acquired Pneumonia
- (2010) D. J. J. van Rensburg et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparative In Vitro Activities of Nemonoxacin (TG-873870), a Novel Nonfluorinated Quinolone, and Other Quinolones against Clinical Isolates
- (2010) T.-L. Lauderdale et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multiple-Dose Safety, Tolerability, and Pharmacokinetics of Oral Nemonoxacin (TG-873870) in Healthy Volunteers
- (2009) D. T. Chung et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Nemonoxacin (TG-873870), a Novel Potent Broad-Spectrum Nonfluorinated Quinolone, in Healthy Volunteers
- (2009) L. Lin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activity of Nemonoxacin, a Novel Nonfluorinated Quinolone, against 2,440 Clinical Isolates
- (2009) H. J. Adam et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In vitro activity of nemonoxacin (TG-873870), a novel non-fluorinated quinolone, against clinical isolates of Staphylococcus aureus, enterococci and Streptococcus pneumoniae with various resistance phenotypes in Taiwan
- (2009) Y.-H. Chen et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Geography and the aetiology of community-acquired pneumonia
- (2009) RESPIROLOGY
- The Epidemic of Antibiotic-Resistant Infections: A Call to Action for the Medical Community from the Infectious Diseases Society of America
- (2007) B. Spellberg et al. CLINICAL INFECTIOUS DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More